New ways to check if liver cancer ablation worked
Part of Cancer, Digestive system clinical trials.
This study tests new criteria for evaluating how well thermal ablation (using heat to destroy cancer nodules) worked in people with hepatocellular carcinoma (HCC, a type of liver cancer). It aims to improve follow-up imaging with contrast-enhanced ultrasound (CEUS) or CT/MRI to see if the treatment was successful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have liver cancer nodules (HCC) that were treated with heat-based ablation (RFA or MWA).
- You agree to take part in the study by signing a consent form.
- You have had at least one contrast-enhanced ultrasound (CEUS) scan after the ablation treatment.
- You have also had a CT or MRI scan after the treatment, and those scans could be evaluated (not marked as 'nonevaluable').
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with liver cancer who are treated with a procedure called radiofrequency ablation (RFA). It aims to create a tool that can predict the chance of the cancer coming back after treatment.
This study follows patients who are having a procedure called thermal ablation to treat liver tumors. It aims to learn more about how well the procedure works and how safe it is.
This trial uses a smart computer program that combines ultrasound and MRI images to plan a more precise heat treatment (ablation) for liver cancer. It aims to destroy the tumor completely while sparing healthy tissue.
This trial compares two types of imaging scans (CEUS and AMRI) to see which one is better at finding liver cancer (HCC) in patients who have an unclear spot on their liver (an indeterminate nodule). It is for people with cirrhosis who have at least one such nodule but no confirmed liver cancer yet.
This trial tests a heat-based treatment for liver cancer tumors that uses multiple methods to destroy cancer cells. It may help people with liver tumors that haven't spread and who are healthy enough for treatment.
This trial compares two ways to treat hepatocellular carcinoma (a type of liver cancer): microwave ablation and laparoscopic hepatectomy (keyhole liver surgery). It may help find which option works better for tumor control and recovery in people with limited, non-spread cancer.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.